rofecoxib has been researched along with Colitis, Granulomatous in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rofecoxib appears to control arthralgia in almost two-thirds of inflammatory bowel disease patients." | 5.11 | Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial. ( Biancone, L; Emerenziani, S; Fina, D; Geremia, A; Pallone, F; Petruzziello, C; Tosti, C, 2004) |
| "Patients with Crohn's disease, ulcerative colitis, or pouchitis who used celecoxib or rofecoxib were identified from computerized prescription records." | 3.71 | Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. ( Loftus, EV; Mahadevan, U; Sandborn, WJ; Tremaine, WJ, 2002) |
| " While these drugs effectively reduce musculoskeletal pain and stiffness, long-term use is limited by gastrointestinal (GI) adverse effects (AEs) and disease exacerbation." | 2.50 | Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. ( Hu, RW; Li, HY; Li, JS; Miao, XP; Ouyang, Q; Zhang, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miao, XP | 1 |
| Li, JS | 1 |
| Ouyang, Q | 1 |
| Hu, RW | 1 |
| Zhang, Y | 1 |
| Li, HY | 1 |
| Gornet, JM | 1 |
| Hassani, Z | 1 |
| Modiglian, R | 1 |
| Lémann, M | 1 |
| Biancone, L | 1 |
| Tosti, C | 1 |
| Geremia, A | 1 |
| Fina, D | 1 |
| Petruzziello, C | 1 |
| Emerenziani, S | 1 |
| Pallone, F | 1 |
| Mahadevan, U | 1 |
| Loftus, EV | 1 |
| Tremaine, WJ | 1 |
| Sandborn, WJ | 1 |
1 review available for rofecoxib and Colitis, Granulomatous
| Article | Year |
|---|---|
Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Colitis, Ulcerative; Crohn Disease; Cyclooxygena | 2014 |
1 trial available for rofecoxib and Colitis, Granulomatous
| Article | Year |
|---|---|
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Colitis, Ulcerative; Crohn Disease | 2004 |
2 other studies available for rofecoxib and Colitis, Granulomatous
| Article | Year |
|---|---|
Exacerbation of Crohn's colitis with severe colonic hemorrhage in a patient on rofecoxib.
Topics: Adult; Colonic Diseases; Crohn Disease; Cyclooxygenase Inhibitors; Female; Gastrointestinal Hemorrha | 2002 |
Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.
Topics: Adult; Aged; Celecoxib; Colitis, Ulcerative; Crohn Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2002 |